Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Journal of the National Cancer Institute|August 3, 1994
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2S A Rosenberg, J R Yannelli, J C Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II studyD R Parkinson, J S Abrams, P H Wiernik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinomaA S Guleria, J C Yang, S L Topalian, et al.
Obesity (Silver Spring, Md.)|June 11, 2011
The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fatE Louise Thomas, James R Parkinson, Gary S Frost, et al.
The Cancer Journal From Scientific American|March 1, 1996
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanomaR E Royal, S M Steinberg, R S Krouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancerDavid R Parkinson, Robert T McCormack, Susan M Keating, et al.
Journal of Translational Medicine|July 4, 2012
Considerations in the development of circulating tumor cell technology for clinical useDavid R Parkinson, Nicholas Dracopoli, Brenda Gumbs Petty, et al.
Pageof 15